{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:00:53Z","timestamp":1740124853164,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41371-020-00436-w","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T16:06:37Z","timestamp":1604937997000},"page":"828-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician\u2019s attitudes toward hypertension treatment"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1115-493X","authenticated-orcid":false,"given":"Cenk","family":"Sar\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersin \u00c7a\u011fr\u0131","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6ner","family":"\u00d6zdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"436_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","volume":"125","author":"XC Li","year":"2017","unstructured":"Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharm Res. 2017;125:21\u201338.","journal-title":"Pharm Res."},{"key":"436_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"Y-Y Zheng","year":"2020","unstructured":"Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259\u201360.","journal-title":"Nat Rev Cardiol."},{"key":"436_CR3","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin\u2013Angiotensin\u2013Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020;382:1653\u20139.","journal-title":"N Engl J Med."},{"key":"436_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u20134.","journal-title":"Nature."},{"key":"436_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","volume":"48","author":"Paz Ocaranza Mar\u00eda","year":"2006","unstructured":"Ocaranza Mar\u00eda Paz, Godoy Ivan, Jalil Jorge E, Varas Manuel, Collantes Patricia, Pinto Melissa, et al. Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat. Hypertension 2006;48:572\u20138.","journal-title":"Hypertension"},{"key":"436_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1440-1681.2009.05302.x","volume":"37","author":"M Huang","year":"2010","unstructured":"Huang M, Li X, Meng Y, Xiao B, Ma Q, Ying S, et al. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clin Exp Pharm Physiol. 2010;37:e1\u20136.","journal-title":"Clin Exp Pharm Physiol"},{"key":"436_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Ishiyama Yuichiro","year":"2004","unstructured":"Yuichiro Ishiyama, Gallagher Patricia E, Averill David B, Ann TallantE, Bridget BrosnihanK, Ferrario Carlos M. Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors. Hypertension. 2004;43:970\u20136.","journal-title":"Hypertension"},{"key":"436_CR8","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"M Ferrario Carlos","year":"2005","unstructured":"Ferrario Carlos M, Jewell Jessup, Chappell Mark C, Averill David B, Bridget BrosnihanK, Ann TallantE, et al. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2. Circulation 2005 ;111:2605\u201310.","journal-title":"Circulation"},{"key":"436_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41569-020-0401-0","volume":"17","author":"I Fern\u00e1ndez-Ruiz","year":"2020","unstructured":"Fern\u00e1ndez-Ruiz I. RAAS inhibitors do not increase the risk of COVID-19. Nat Rev Cardiol. 2020;17:383\u2013383.","journal-title":"Nat Rev Cardiol."},{"key":"436_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41371-020-0356-y","volume":"34","author":"SK Nadar","year":"2020","unstructured":"Nadar SK, Tayebjee MH, Stowasser M, Byrd JB. Managing hypertension during the COVID-19 pandemic. J Hum Hypertens. 2020;34:415\u20137.","journal-title":"J Hum Hypertens"},{"key":"436_CR11","doi-asserted-by":"publisher","unstructured":"Doumas M, Patoulias D, Katsimardou A, Stavropoulos K, Imprialos K, Karagiannis A. COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute? J Hum Hypertens. 2020;1\u20134. https:\/\/doi.org\/10.1038\/s41371-020-0380-y. Epub ahead of print.","DOI":"10.1038\/s41371-020-0380-y"},{"key":"436_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","volume":"26","author":"B Bozkurt","year":"2020","unstructured":"Bozkurt B, Kovacs R, Harrington B. Joint HFSA\/ACC\/AHA Statement Addresses Concerns Re: using RAAS Antagonists in COVID-19. J Card Fail. 2020;26:370.","journal-title":"J Card Fail"},{"key":"436_CR13","first-page":"e21","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet. Respir Med. 2020;8:e21.","journal-title":"Respir Med"},{"key":"436_CR14","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-J Guan","year":"2020","unstructured":"Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med."},{"key":"436_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"436_CR16","doi-asserted-by":"crossref","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574\u201381.","DOI":"10.1001\/jama.2020.5394"},{"key":"436_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41440-020-0485-2","volume":"43","author":"S Huang","year":"2020","unstructured":"Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertension Res. 2020;43:824\u201331.","journal-title":"Hypertension Res"},{"key":"436_CR18","doi-asserted-by":"crossref","unstructured":"Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020;81:537\u201340.","DOI":"10.1002\/ddr.21656"},{"key":"436_CR19","doi-asserted-by":"publisher","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","volume":"314","author":"CP Sodhi","year":"2018","unstructured":"Sodhi CP, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton WB, Wang S, et al. Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Physiol Lung Cell Mol Physiol. 2018;314:L17\u201331.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"436_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364\u201374.","journal-title":"Sci China Life Sci"},{"key":"436_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep19840","volume":"6","author":"H Gu","year":"2016","unstructured":"Gu H, Xie Z, Li T, Zhang S, Lai C, Zhu P, et al. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep. 2016;6:19840.","journal-title":"Sci Rep."},{"key":"436_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4594","volume":"5","author":"Z Zou","year":"2014","unstructured":"Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun. 2014;5:3594.","journal-title":"Nat Commun"},{"key":"436_CR23","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin\u2013Angiotensin\u2013Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020;382:2431\u201340.","journal-title":"N Engl J Med"},{"key":"436_CR24","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020;382:2441\u20138.","journal-title":"N Engl J Med"},{"key":"436_CR25","doi-asserted-by":"crossref","unstructured":"Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020;323:1612\u20134.","DOI":"10.1001\/jama.2020.4326"},{"key":"436_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMc2005396","volume":"383","author":"S-C Chung","year":"2020","unstructured":"Chung S-C, Providencia R, Sofat R. Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom. N Engl J Med. 2020;383:397\u2013400.","journal-title":"N Engl J Med"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-020-00436-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-020-00436-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-020-00436-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T23:06:23Z","timestamp":1633907183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-020-00436-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1038\/s41371-020-00436-w","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"type":"print","value":"0950-9240"},{"type":"electronic","value":"1476-5527"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All subjects gave informed consent for participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}